FDA proposals to ease restrictions on the use and sale of experimental drugs : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One hundredth Congress, first session, April 29, 1987.

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992.
Published: (1993)

FDA regulatory affairs : a guide for prescription drugs, medical devices, and biologics /
Published: (2004)

The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007.
Published: (2007)

The adequacy of FDA to assure the safety of the nation's drug supply : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, February 13, March 22, 2007.
Published: (2007)

FDA has made progress on oversight and inspections of manufacturers of generic drugs.
Published: (2015)

Las drogas baratas aprobadas por la FDA : los productos genéricos deben satisfacer altos niveles.
Published: (2004)

FDA's generic drug enforcement and approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, first session, March 7 and June 5, 1991.
Published: (1992)

FDA's Faulty Safeguards Against Corruption : Concerns over Debarment Use and Authority.
Published: (2008)

Drug safety: FDA has faced persistent challenges overseeing foreign drug manufacturing : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representative /
by: Denigan-Macauley, Mary
Published: (2024)

The administration's FDA reforms and reduced biopharmaceutical drug prices /
Published: (2018)

Drug shortages : FDA's ability to respond should be strengthened : report to congressional requesters.
Published: (2011)

El proceso del desarrollo de las drogas y la FDA : cómo la agencia asegura que las drogas sean seguras y efectivas.
Published: (2002)

Prescription drugs : FDA's oversight of the promotion of drugs for off-label uses : report to the Ranking Member, Committee on Finance, U.S. Senate.
Published: (2008)

FDA medical bulletin.
Published: (1991)

Drug shortages : FDA's ability to respond should be strengthened : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate /
by: Crosse, Marcia
Published: (2011)

Review Panel on New Drug Regulation : final report.
Published: (1977)

Prescription Drugs : FDA Guidance and Regulations Related to Data on Elderly Persons in Clinical Drug Trials.
Published: (2007)

Decline in FDA Enforcement Efforts.
Published: (2005)

The Food and Drug Administration's process for approving new drugs : report /
Published: (1980)

FDA's regulation of the new drug Suprol : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, One Hundredth Congress, first session, May 27, 1987.
Published: (1988)

FDA drug approval : review time has decreased in recent years : report to congressional requesters.
Published: (1995)

Drug Listing Act of 1972.
Published: (1972)

Drug compounding for animals : FDA could improve oversight with better information and guidance : report to congressional committees.
Published: (2015)

Drug safety : better data management and more inspections are needed to strengthen FDA's foreign drug inspection program : report to congressional requesters.
Published: (2008)

Drug regulation reform--oversight : hearing before the Subcommittee on Health and the Environment of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, second session ...
Published: (1980)

Man-in-the-plant : FDA's failure to regulate deceptive drug labeling : report together with separate views /
Published: (1978)

FDA interim index to evaluations published in the Federal register for NAS-NRC reviewed prescription drugs.
Published: (1976)

The Food and Drug Administration (FDA) /
Published: (2003)

Drug compounding, FDA has taken steps to implement compounding law, but some states and stakeholders reported challenges : report to Congressional Committees.
Published: (2016)

Advisory Committee on the Food and Drug Administration : final report : hearing of the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on reviewing the Advisory Committee on the Food and Drug Administration report on the current state of FDA, and its recommendations to strengthen FDA, May 15, 1991.
Published: (1992)

Drug lag : hearing before the Subcommittee on Natural Resources, Agriculture Research, and Environment of the Committee on Science and Technology, U.S. House of Representatives, Ninety-seventh Congress, first session, September 16, 1981.
Published: (1983)

FDA Checkup : Drug Development and Manufacturing Challenges.
Published: (2013)

The FDA prescription drug file.
Published: (1991)